Cargando…

Thalidomide and Phosphodiesterase 4 Inhibitors as Host Directed Therapeutics for Tuberculous Meningitis: Insights From the Rabbit Model

Tuberculous meningitis (TBM) is the most devastating form of extrapulmonary Mycobacterium tuberculosis infection in humans. Severe inflammation and extensive tissue damage drive the morbidity and mortality of this manifestation of tuberculosis (TB). Antibiotic treatment is ineffective at curing TBM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Ranjeet, Kolloli, Afsal, Singh, Pooja, Vinnard, Christopher, Kaplan, Gilla, Subbian, Selvakumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972508/ https://www.ncbi.nlm.nih.gov/pubmed/32010638 http://dx.doi.org/10.3389/fcimb.2019.00450

Ejemplares similares

A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023)

Aggregation state of Mycobacterium tuberculosis impacts host immunity and augments pulmonary disease pathology
por: Kolloli, Afsal, et al.
Publicado: (2021)

An improved protocol to establish experimental tuberculous meningitis in the rabbit
por: O'Brien, Paul, et al.
Publicado: (2020)

Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)

Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
por: Kumar, Ranjeet, et al.
Publicado: (2021)

Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
por: Kumar, Ranjeet, et al.
Publicado: (2019)

Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection
por: Ramasamy, Santhamani, et al.
Publicado: (2022)

Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection
por: Kolloli, Afsal, et al.
Publicado: (2019)

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis
por: Mezochow, Alyssa, et al.
Publicado: (2019)

Imaging Architecture of Granulomas Induced by Mycobacterium tuberculosis Infections with Single-Molecule FISH
por: Kumar, Ranjeet, et al.
Publicado: (2023)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2016)

An intra-cytoplasmic route for SARS-CoV-2 transmission unveiled by Helium-ion microscopy
por: Merolli, Antonio, et al.
Publicado: (2022)

Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
por: Subbian, Selvakumar, et al.
Publicado: (2016)

Editorial: Innate immune evasion strategies during microbial infection
por: Subbian, Selvakumar
Publicado: (2023)

Phosphodiesterase-4 Inhibition Alters Gene Expression and Improves Isoniazid – Mediated Clearance of Mycobacterium tuberculosis in Rabbit Lungs
por: Subbian, Selvakumar, et al.
Publicado: (2011)

A Diagnostic Formula for Discrimination of Tuberculous and Bacterial Meningitis Using Clinical and Laboratory Features
por: Yang, Yun, et al.
Publicado: (2020)

Genome-Wide miRNA Analysis Identifies Potential Biomarkers in Distinguishing Tuberculous and Viral Meningitis
por: Pan, Liping, et al.
Publicado: (2019)

Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
por: Subbian, Selvakumar, et al.
Publicado: (2011)

Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis
por: Wen, An, et al.
Publicado: (2022)

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response
por: Campbell, Elliot, et al.
Publicado: (2023)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
por: Manca, Claudia, et al.
Publicado: (2013)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
por: Koo, Mi-Sun, et al.
Publicado: (2012)

Thalidomide in the treatment of human immunodeficiency virus-negative tuberculous meningitis: A case report
por: Liu, Ping, et al.
Publicado: (2020)

Phosphodiesterase 4 Inhibition Reduces Innate Immunity and Improves Isoniazid Clearance of Mycobacterium tuberculosis in the Lungs of Infected Mice
por: Koo, Mi-Sun, et al.
Publicado: (2011)

Editorial: Insights in virus and host: 2021
por: Hiscott, John, et al.
Publicado: (2023)

Isoniazid-Resistant Tuberculous Meningitis, United States, 1993–2005
por: Vinnard, Christopher, et al.
Publicado: (2011)

Tuberculous meningitis: where to from here?
por: Donovan, Joseph, et al.
Publicado: (2020)

The Phosphodiesterase Inhibitor Tadalafil Promotes Splenic Retention of Plasmodium falciparum Gametocytes in Humanized Mice
por: Barbieri, Daniela, et al.
Publicado: (2022)

Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study
por: Vinnard, Christopher, et al.
Publicado: (2010)

Editorial: New insights in Chlamydia: host interactions and pathogenesis
por: Saka, Hector Alex, et al.
Publicado: (2023)

Host Directed Therapies for Tuberculous Meningitis
por: Davis, Angharad G., et al.
Publicado: (2021)

Streptococcus pneumoniae meningitis and the CNS barriers
por: Gil, Eliza, et al.
Publicado: (2023)

Metagenomic next-generation sequencing assistance in identifying non-tuberculous mycobacterial infections
por: Wang, Shilei, et al.
Publicado: (2023)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Structural and Evolutionary Insights Into the Binding of Host Receptors by the Rabies Virus Glycoprotein
por: Khalifa, Manar E., et al.
Publicado: (2021)

Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs
por: Gu, Yuzhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8u3843vmqfhbcp4iidk3kaeqs